Gan & Lee Pharmaceuticals Co., Ltd. announced that the US FDA has cleared the Investigational New Drug application for the company’s compound, GZR18, to improve the management of type 2 diabetes mellitus.
[Gan & Lee Pharmaceuticals Co., Ltd.]
Sorry, but the selected Zotpress account can't be found.